Physician

Alvin Li

According to 2025 Medicare claims, Alvin Li (NPI: 1225531007) practices dermatology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Mateo, CA. This provider's primary affiliated billing organization is CSI MEDICAL GROUP (NPI: 1871909804; TIN: 471108040) and primary practice location at 94401-2778.

Li's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 621 traditional Medicare patients, billed 4,058 HCPCS/CPT codes, and received $784,967 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 693 prescription claims across 396 beneficiaries totaling $49,457 in drug costs, led by Doxycycline Hyclate (Doxycycline Hyclate). Open Payments data shows 82 records totaling $1,826. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,227 to $49,457. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$392K$785K2022 Medicare payment: $82,926 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $401,689 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $784,967 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022163752$82,926
20234832,765$401,689
20246214,058$784,967

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$49K2018 Drug cost: $1,227 (USD; Tot_Drug_Cst)2019 Drug cost: $6,269 (USD; Tot_Drug_Cst)2022 Drug cost: $2,903 (USD; Tot_Drug_Cst)2023 Drug cost: $9,704 (USD; Tot_Drug_Cst)2024 Drug cost: $49,457 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181843$1,227
20192854$6,269
2020N/RN/RN/R
2021N/RN/RN/R
202281144$2,903
2023257427$9,704
2024396693$49,457

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks294367$458
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm130142$226
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more272355$112
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more257439$75
17000Destruction of precancer skin growth, 1 growth137224$49

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Doxycycline HyclateDoxycycline Hyclate3672,612$2,477
Clobetasol PropionateClobetasol Propionate361,064$1,890
TacrolimusTacrolimus11345$1,159
KetoconazoleKetoconazole521,340$735
Triamcinolone AcetonideTriamcinolone Acetonide381,280$496

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.82$1,826ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alvin Li?

Tedicare shows public-source Medicare data for Alvin Li (NPI 1225531007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alvin Li have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alvin Li?

Alvin Li is linked to CSI MEDICAL GROUP (billing NPI 1871909804) in the available physician profile data.

Does Alvin Li have Open Payments data?

Alvin Li has 82 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.